{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:11:39Z","timestamp":1778670699280,"version":"3.51.4"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2009,4,15]]},"DOI":"10.1086\/597469","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T00:55:58Z","timestamp":1236732958000},"page":"1123-1128","source":"Crossref","is-referenced-by-count":54,"title":["Etravirine, a Next\u2010Generation Nonnucleoside Reverse\u2010Transcriptase Inhbitor"],"prefix":"10.1093","volume":"48","author":[{"given":"Leonard\u00a0B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis\u00a0D.","family":"Saravolatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/48\/8\/1123\/964019\/48-8-1123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T18:35:21Z","timestamp":1503426921000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/597469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,4,15]]}},"alternative-id":["10.1086\/597469"],"URL":"https:\/\/doi.org\/10.1086\/597469","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}